February 02, 2022
Article
A man describes his wife’s tireless efforts to advocate for people of color in the metastatic breast cancer field, where many still face disparities within care, inclusion in clinical trials and survival outcomes.
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC